anonymous
Guest
anonymous
Guest
That’s about right. Worthless division. They couldn’t talk to a doc if they had to. Cut them loose. Waste of money
Sure, pharma rep.That’s about right. Worthless division. They couldn’t talk to a doc if they had to. Cut them loose. Waste of money
That’s about right. Worthless division. They couldn’t talk to a doc if they had to. Cut them loose. Waste of money
That’s about right. Worthless division. They couldn’t talk to a doc if they had to. Cut them loose. Waste of money
Yep
PC3 is the least desirable sales division to be in through all of Lilly.
Emgality is done. It’s weighted 30% wholly based on district performance = nobody promoting it so there goes 30% of my potential $6,000 bonus. Lol great.
Jardiance is a dying drug. It’ll still be used for a while but growth is completely gone.
If PC3 isn’t assigned a new large market drug in the next 1-2 years then this division will collapse.
As said above, contract reps will continue to play larger & larger roles. Jardiance is a service call, sample drop product within 1 year after CKD launches
Karma will address your mean-spirited comment; we’re all a patent expiration, or competing molecule, or poor upper Management decision away from being in the same boat. Here’s hoping you realize that sooner than later.
Please dear 8 Oz baby Jesus let there be an obesity sales force that we can run away from PC3
Very well saidI have a lot to say about this. I like my job. I like my offices. I like selling Jardiance and Emgality and I’ll sell whatever they ask me to sell. What I don’t like is the metric-heavy micromanagement and what it has turned being a rep into.
8.5 calls a day on company data directed targets isn’t the reality of who you can see and have influence over in the field. No see systems are a reality across the country and yet these are the targets dropping into our call plans with no way of removing them. They want me to see a doctor 6 times that I have 0 access to? What back door do they think I can magically access? Truthfully, I should only enter service calls on them but then my reach, frequency, and attainment are going to suffer. So then what do we do because we have no choice? The obvious result is - stretching the truth. Or in many reps cases, flat out lying.
Lilly has us complete Red Book training on ethics and then force our hands into making metrics supersede what we know wasn’t a real call. How can we change it? We can’t. Our managers know what is going on. They can tell their managers but it doesn’t matter because some moron at the top things that the targets Javelin gives us are the end all be all for moving business. The BI contract is too important (or expensive) I guess. So this quarter it’s all about reach, frequency, and attainment when that truly had no ability to change prescription outcomes, but makes the tidy numbers line up to keep Lilly and BI buddies. *RANT*
CKD indication, pediatric indication?, and maybe mounjaro coming our way? Who knows. But nothing about this push for metrics is making us sell a damn thing. Just keep paying me and I’ll do the best I can with what I have been given.
I have a lot to say about this. I like my job. I like my offices. I like selling Jardiance and Emgality and I’ll sell whatever they ask me to sell. What I don’t like is the metric-heavy micromanagement and what it has turned being a rep into.
8.5 calls a day on company data directed targets isn’t the reality of who you can see and have influence over in the field. No see systems are a reality across the country and yet these are the targets dropping into our call plans with no way of removing them. They want me to see a doctor 6 times that I have 0 access to? What back door do they think I can magically access? Truthfully, I should only enter service calls on them but then my reach, frequency, and attainment are going to suffer. So then what do we do because we have no choice? The obvious result is - stretching the truth. Or in many reps cases, flat out lying.
Lilly has us complete Red Book training on ethics and then force our hands into making metrics supersede what we know wasn’t a real call. How can we change it? We can’t. Our managers know what is going on. They can tell their managers but it doesn’t matter because some moron at the top things that the targets Javelin gives us are the end all be all for moving business. The BI contract is too important (or expensive) I guess. So this quarter it’s all about reach, frequency, and attainment when that truly had no ability to change prescription outcomes, but makes the tidy numbers line up to keep Lilly and BI buddies. *RANT*
CKD indication, pediatric indication?, and maybe mounjaro coming our way? Who knows. But nothing about this push for metrics is making us sell a damn thing. Just keep paying me and I’ll do the best I can with what I have been given.
Pc3 are worthless. They don’t sell as it is. Some are good. Most…not. Obesity indication needs a new group,.. experienced who can actually talk to office staff and providers,
Have you ever saw that meme, the one with the three spidermen pointing at each other claiming the other one is the imposter, but they're all three the same thing?
That's basically PC1,2&3
We're all sample droppers and lunchboys. The only difference is PC3 knows that, but y'all too stupid to figure it out.
Mounjaro launched itself, y'all didn't do shit. Two monkeys throwing feces at themselves could have launched it as well as you did. I mean damn, best in class weight loss, enough samples to bribe offices, and the rolls Royce of copay cards and y'all wanna pat yourself on the back like you did something. Ooooookayyy.
You ain't special.
Have you ever saw that meme, the one with the three spidermen pointing at each other claiming the other one is the imposter, but they're all three the same thing?
That's basically PC1,2&3
We're all sample droppers and lunchboys. The only difference is PC3 knows that, but y'all too stupid to figure it out.
Mounjaro launched itself, y'all didn't do shit. Two monkeys throwing feces at themselves could have launched it as well as you did. I mean damn, best in class weight loss, enough samples to bribe offices, and the rolls Royce of copay cards and y'all wanna pat yourself on the back like you did something. Ooooookayyy.
You ain't special.
I have a lot to say about this. I like my job. I like my offices. I like selling Jardiance and Emgality and I’ll sell whatever they ask me to sell. What I don’t like is the metric-heavy micromanagement and what it has turned being a rep into.
8.5 calls a day on company data directed targets isn’t the reality of who you can see and have influence over in the field. No see systems are a reality across the country and yet these are the targets dropping into our call plans with no way of removing them. They want me to see a doctor 6 times that I have 0 access to? What back door do they think I can magically access? Truthfully, I should only enter service calls on them but then my reach, frequency, and attainment are going to suffer. So then what do we do because we have no choice? The obvious result is - stretching the truth. Or in many reps cases, flat out lying.
Lilly has us complete Red Book training on ethics and then force our hands into making metrics supersede what we know wasn’t a real call. How can we change it? We can’t. Our managers know what is going on. They can tell their managers but it doesn’t matter because some moron at the top things that the targets Javelin gives us are the end all be all for moving business. The BI contract is too important (or expensive) I guess. So this quarter it’s all about reach, frequency, and attainment when that truly had no ability to change prescription outcomes, but makes the tidy numbers line up to keep Lilly and BI buddies. *RANT*
CKD indication, pediatric indication?, and maybe mounjaro coming our way? Who knows. But nothing about this push for metrics is making us sell a damn thing. Just keep paying me and I’ll do the best I can with what I have been given.
Leaving was the best move I ever made! The grass IS greener elsewhere.
I. WANT. OUT. of PC3
The desperate strategy of using JR before MET is not working. What a joke of a strategy but after 8 years with no new info I guess that’s all that’s left to try?
Where is the advantage to grow Jardiance?
A1C… nope
Weight loss…nope
CVD … lol.. nope
CKD… lmao.. nope
Coverage & cost?….uhhh nope. Farxiga is free with co-pay card, oh plus 2 free months of vouchers
EGFR rates…. Try again .. another nope
Even our team is worse trying to co-promote with another company
Don’t even ask me how poorly we stack up to GLP-1s & Mounjaro